We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$1.02B
Cap. Flow
+$618M
Cap. Flow %
4.47%
Top 10 Hldgs %
12.42%
Holding
2,126
New
119
Increased
1,428
Reduced
493
Closed
63

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.5M
2
WMT icon
Walmart Inc
WMT
+$16.8M
3
IBM icon
IBM
IBM
+$16.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$15.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$14.5M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 14.95%
3 Healthcare 13.94%
4 Consumer Staples 9.08%
5 Industrials 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EZPW icon
2001
Ezcorp Inc
EZPW
$1.79B
$131K ﹤0.01%
11,817
-115
-1% -$1.11K
FORM icon
2002
FormFactor
FORM
$6.51B
$131K ﹤0.01%
12,028
INVA icon
2003
Innoviva
INVA
$1.6B
$130K ﹤0.01%
11,836
+169
+1% +$1.97K
HOS
2004
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$128K ﹤0.01%
23,311
-988
-4% -$6.43K
FPO
2005
DELISTED
First Potomac Realty Trust
FPO
$127K ﹤0.01%
+13,890
New +$134K
ISBC
2006
DELISTED
Investors Bancorp, Inc.
ISBC
$124K ﹤0.01%
+10,352
New +$120K
SGYP
2007
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$123K ﹤0.01%
22,346
+7,249
+48% +$33.9K
VG
2008
DELISTED
Vonage Holdings Corporation
VG
$123K ﹤0.01%
18,642
+1,341
+8% +$8.06K
MUX icon
2009
McEwen Inc
MUX
$1B
$121K ﹤0.01%
3,284
+176
+6% +$7.25K
AVTA
2010
DELISTED
Avantax, Inc. Common Stock
AVTA
$121K ﹤0.01%
+10,761
New +$120K
CROX icon
2011
Crocs
CROX
$6.63B
$117K ﹤0.01%
14,041
+479
+4% +$4.59K
EGO icon
2012
Eldorado Gold
EGO
$8.33B
$114K ﹤0.01%
5,808
+135
+2% +$2.79K
LIOX
2013
DELISTED
Lionbridge Technologies
LIOX
$114K ﹤0.01%
22,867
+2,851
+14% +$13.4K
LQDT icon
2014
Liquidity Services
LQDT
$1.2B
$113K ﹤0.01%
10,076
-4,411
-30% -$40.7K
VALE.P
2015
DELISTED
Vale S A
VALE.P
$113K ﹤0.01%
24,064
-3,550
-13% -$16.1K
RPTP
2016
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$112K ﹤0.01%
12,537
+1,315
+12% +$9.35K
ARRY
2017
DELISTED
Array Biopharma Inc
ARRY
$111K ﹤0.01%
16,494
+1,978
+14% +$7.65K
CZR
2018
DELISTED
Caesars Entertainment Corporation
CZR
$111K ﹤0.01%
14,929
+1,128
+8% +$8.12K
HAPN
2019
Happen Inc
HAPN
$2.14B
$110K ﹤0.01%
3,560
-54
-1% -$1.4K
OMN
2020
DELISTED
OMNOVA Solutions Inc.
OMN
$105K ﹤0.01%
12,412
+558
+5% +$5.2K
DAKT icon
2021
Daktronics
DAKT
$946M
$104K ﹤0.01%
10,905
-5,927
-35% -$47.1K
ARNA
2022
DELISTED
Arena Pharmaceuticals Inc
ARNA
$104K ﹤0.01%
5,920
-1,854
-24% -$30.7K
INWK
2023
DELISTED
InnerWorkings, Inc.
INWK
$101K ﹤0.01%
+10,703
New +$93.4K
HMY icon
2024
Harmony Gold Mining
HMY
$9.7B
$94K ﹤0.01%
26,880
ENOC
2025
DELISTED
EnerNOC, Inc.
ENOC
$92K ﹤0.01%
17,039
-2,483
-13% -$15.1K

Similar funds

Aperio Group's Q3 2016 Portfolio in Review

As of Q3 2016, Aperio Group held 2,126 positions worth $13.8B, up 8% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $618M of net new capital in Q3 2016, opening 119 new positions and adding to 1,428 existing holdings. Its largest new stake was Fortive: 345,212 shares worth $11.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.5M trimmed.

  • Aperio Group's largest Q3 2016 buy was Fortive: 345,212 shares worth $11.1M.
  • Aperio Group added most to Apple in Q3 2016, an estimated $22.5M increase.
  • Aperio Group's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $8.5M.
  • Aperio Group fully exited EMC CORPORATION in Q3 2016, selling an estimated $26.9M.
  • Aperio Group's ten largest holdings make up 12% of its $13.8B portfolio in Q3 2016.
  • Aperio Group opened 119 new positions and closed 63 in Q3 2016.
  • Aperio Group's portfolio value rose 8% quarter-over-quarter to $13.8B.

Based on Aperio Group's 13F filing for Q3 2016, filed 2 Nov 2016.